7 results found
https://www.federalregister.gov/documents/2022/11/23/2022-23918/medicare-program-hospital-…

…clitaxel works as an anti-proliferative drug that stops new tissue growth and prevents fibrotic scarring that may result in stricture recurrence. For CY 2023, we proposed to delete CPT code 0499T. We note that in the OPPS Addendum B of the CY 2023 OPPS/ASC proposed rule, the code…

https://www.federalregister.gov/public-inspection/2024-25521/medicare-and-medicaid-program…

…tes a beneficial outcome, such as the use of intravenous pain medications, or prevents possible complications, such as the use of intravenous blood pressure medications to temporarily replace oral blood pressure medications and reduce the risk of a sudden rise in blood pressure w…

https://www.federalregister.gov/documents/2020/12/29/2020-26819/medicare-program-hospital-…

…products. Also, claim lines billed with P9099 are rejected by Medicare, which prevents providers from tracking the utilization of unclassified blood products. Because of the challenges of determining an appropriate payment rate for unclassified blood products, we stated in the CY…

https://www.federalregister.gov/documents/2019/11/12/2019-24138/medicare-program-changes-t…

…y exercises, in addition to providing standard step count and high-acceleration events that may indicate a fall. A temperature sensor monitors the skin temperature near the joint. TracPatch is described by the applicant as a 24/7 remote monitoring wearable device that captures a …